Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: The MARKED (Multi mARKer Emergency Dyspnea)-risk score

Journal of the American College of Cardiology

Volumn 60, Issue 17, 2012, Pages 1668-1677

  Eurlings, Luc W ^a   Sanders Van Wijk, Sandra ^a   Van Kimmenade, Roland ^b   Osinski, Aart ^a   Van Helmond, Lidwien ^a   Vallinga, Maud ^a   Crijns, Harry J ^a   Van Dieijen Visser, Marja P ^c   Brunner La Rocca, Hans Peter ^a   Pinto, Yigal M ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

biomarkers; Cystatin C; dyspnea; Galectin 3; heart failure; high sensitivity C reactive protein; high sensitivity cardiac troponin T; N terminal pro BNP; prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; GALECTIN 3; HIGH SENSITIVITY C REACTIVE PROTEIN; HIGH SENSITIVITY CARDIAC TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE MARKER; DYSPNEA; EMERGENCY WARD; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INCIDENCE; MALE; NETHERLANDS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84867578067     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.06.040     Document Type: Article

References (54)

1. H.L. Manning, R.M. Schwartzstein Pathophysiology of dyspnea N Engl J Med 333 1995 1547 1553
2. E. Michelson, S. Hollrah Evaluation of the patient with shortness of breath: an evidence based approach Emerg Med Clin North Am 17 1999 221 237
3. E.M. Antman, M. Cohen, P.J.L.M. Bernink The TIMI risk score for unstable angina/non-ST elevation MI JAMA 284 2000 835 842
4. K.A. Eagle, M.J. Lim, O.H. Dabbous A validated prediction model for all forms of acute coronary syndrome JAMA 291 2004 2727 2733
5. M.R. Nendaz, P. Bandelier, D. Aujesky Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome Thromb Haemost 91 2004 1232 1236
6. A.L. Baggish, D. Lloyd-Jones, J. Blatt A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme Heart 94 2008 1032 1037
7. A. Clerico, M. Fontana, L. Zyw, C. Passino, M. Emdin Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review Clin Chem 53 2007 813 822
8. B. Dieplinger, A. Gegenhuber, G. Kaar, W. Poelz, M. Haltmayer, T. Mueller Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department Clin Biochem 43 2010 714 719
9. A. Maisel, C. Mueller, R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
10. S. Manzano-Fernández, M. Boronat-Garcia, M.D. Albaladejo- Otón Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic peptide and cardiac troponin T in patients with acute heart failure Am J Cardiol 103 2009 1753 1759
11. D.A. Pascual-Figal, S. Manzano-Fernández, M. Boronat Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure Eur J Heart Fail 13 2011 718 725
12. R.R. van Kimmenade, J.L. Januzzi Jr., P.T. Ellinor Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 2006 1217 1224
13. M.N. Zairis, G.Z. Tsiaousis, A.T. Georgilas Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure Int J Cardiol 141 2010 284 290
14. R.R.J. van Kimmenade, J.L. Januzzi Jr. Emerging biomarkers in heart failure Clin Chem 58 2012 121 138
15. W. Frank Peacock, R. Nowak, R. Christenson Short-term mortality risk in emergency department acute heart failure Acad Emerg Med 18 2011 947 958
16. L.H. Jacobs, J.J. Van De Kerkhof, A.M. Mingels Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study Nephrol Dial Transplant 25 2010 243 248
17. W.L. Roberts, L. Moulton, T.C. Law Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications Part 2 Clin Chem 47 2001 418 425
18. A. Mingels, L. Jacobs, E. Michielsen, J. Swaanenburg, W. Wodzig, M. van Dieijen-Visser Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays Clin Chem 55 2009 101 108
19. R.H. Christenson, S.H. Duh, A.H.B. Wu Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure Clin Biochem 43 2010 683 690
20. J. Li, W. Dunn, A. Breaud, D. Elliott, L.J. Sokoll, W. Clarke Analytical performance of 4 automated assays for measurement of cystatin C Clin Chem 56 2010 1336 1339
21. E.J. Uhlmann, K.G. Hock, C. Issitt Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II System, and correlation with creatinine Clin Chem 41 2001 2031 2033
22. M.A. Hlatky, P. Greenland, D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
23. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12
24. E.W. Steyerberg, F.E. Harrell, G.J.J.M. Borsboom, M. Eijkemans, Y. Vergouwe, J.D.F. Habbema Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781
25. N.A. Khan, B.R. Hemmelgarn, M. Tonelli, C.R. Thompson, A. Levin Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease Circulation 112 2005 3088 3096
26. R. Latini, S. Masson, I.S. Anand Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 2007 1242 1249
27. T. Omland, J.A. de Lemos, M.S. Sabatine A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med 361 2009 2538 2547
28. M. Lankeit, D. Friesen, J. Aschoff Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism Eur Heart J 31 2010 1836 1844
29. W.F. Peacock IV, T. De Marco, G.C. Fonarow Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126
30. S. van Wijk, L. Jacobs, L.W. Eurlings Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea Clin Chem 58 2012 284 292
31. J.A. de Lemos, M.H. Drazner, T. Omland Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population JAMA 304 2010 2503 2512
32. W.H. Yin, J.W. Chen, H.L. Jen Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 2004 931 938
33. I.S. Anand, R. Latini, V.G. Florea C-reactive protein in heart failure Circulation 112 2005 1428 1434
34. J.D. Windram, P.H. Loh, A.S. Rigby, I. Hanning, A.L. Clark, J.G.F. Cleland Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure Am Heart J 153 2007 1048 1055
35. S. Rehman, D.M. Lloyd-Jones, A. Martinez-Rumayor, J.L. Januzzi Jr Inflammatory markers, amino-terminal pro-brain natriuretic peptide, and mortality risk in dyspneic patients Am J Clin Pathol 130 2008 305 311
36. S.U. Rehman, A. Martinez-Rumayor, T. Mueller, J.L. Januzzi Jr. Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Clin Chim Acta 392 2008 41 45
37. R.A. de Boer, D.J. van Veldhuisen, R.T. Gansevoort The fibrosis marker galectin-3 and outcome in the general population: data from PREVEND J Intern Med 272 2012 55 64
38. D.J.A. Lok, P. Van Der Meer, P.W.B.A. de la Porte Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Clin Res Cardiol 99 2010 323 328
39. G.M. Felker, M. Fiuzat, L.K. Shaw Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study Circ Heart Fail 5 2011 72 78
40. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, R.R.J. van Kimmenade, J.L. Januzzi Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 2010 826 832
41. A.O. Grubb Cystatin C-properties and use as diagnostic marker Adv Clin Chem 35 2001 63 99
42. J. Lassus, V.P. Harjola, R. Sund Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur Heart J 28 2007 1841 1847
43. M.J. Sarnak, R. Katz, C.O. Stehman-Breen Cystatin C concentration as a risk factor for heart failure in older adults Ann Intern Med 142 2005 497 505
44. J.L. Januzzi, R. Van Kimmenade, J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients Eur Heart J 27 2006 330 337
45. J.L. Januzzi, C.A. Camargo, S. Anwaruddin The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
46. A.M. Medina, M.S. Marteles, E.B. Sáiz Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases Eur J Intern Med 22 2011 167 171
47. D. Stolz, T. Breidthardt, M. Christ-Crain Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD Chest 133 2008 1088 1094
48. E.W. Steyerberg, M.J.C. Eijkemans, J.D.F. Habbema Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis J Clin Epidemiol 52 1999 935 942
49. B.F. Gage, C. van Walraven, L. Pearce Selecting patients with atrial fibrillation for anticoagulation Circulation 110 2004 2287 2292
50. G.Y.H. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, H.J.G.M. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach Chest 137 2010 263 272
51. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. De Vos, H.J.G.M. Crijns, G.Y.H. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation Chest 138 2010 1093 1100
52. A. Maisel, C. Mueller, R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
53. P.A. McCullough, R.M. Nowak, J. McCord B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure Circulation 106 2002 416 422
54. D.G. Altman, Y. Vergouwe, P. Royston, K.G.M. Moons Prognosis and prognostic research: validating a prognostic model [abstract] BMJ 338 2009 b605